ImmunomeIMNM 
$15.500.65%24h
0.65%24h
Global rank9572
Market cap$697.94M
Change 7d-0.77%
YTD Performance43.52%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of Immunome (IMNM)
As of December 2024, Immunome has a market cap of $697.94M. This makes Immunome the world's 9572th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Immunome from 2020 to 2024
-
Value:-
Market cap history of Immunome from 2020 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $1.01B | 109.91% |
| 2023 | $481.80M | 384.16% |
| 2022 | $99.51M | -82.95% |
| 2021 | $583.57M | 33.88% |
| 2020 | $435.87M | - |
IMNM Market Cap Today is $697.94M 0.65% - 1 Dec 2024
View largest stocks by market cap 
